Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Puma Biotechnology (NQ: PBYI )

4.280 -0.020 (-0.47%)
Streaming Delayed Price Updated: 2:43 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 221,842
Open 4.340
Bid (Size) 4.270 (3)
Ask (Size) 4.280 (7)
Prev. Close 4.300
Today's Range 4.200 - 4.430
52wk Range 1.600 - 5.160
Shares Outstanding 45,640,135
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Breast Cancer with a HER2 Mutation
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Present at B. Riley Securities’ 3rd Annual Oncology Conference
From Puma Biotechnology, Inc.
Via Business Wire

Performance

YTD
+3.63%
+3.63%
1 Month
+3.63%
+3.63%
3 Month
+90.22%
+90.22%
6 Month
+45.08%
+45.08%
1 Year
+73.98%
+73.98%

More News

Read More
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Why Shares of Puma Biotechnology Rose This Week
Via The Motley Fool
Puma Biotechnology Releases Updated Corporate Presentation
From Puma Biotechnology, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Why Puma Biotechnology's Shares Jumped 20% on Monday
Via The Motley Fool
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings
Via Benzinga
S&P 500 Down 1%; Crude Oil Drops Sharply
Via Benzinga
Short Volatility Alert: Puma Biotechnology, Inc.
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Puma Biotechnology Reports Third Quarter 2022 Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Via Benzinga
Puma Biotechnology's Earnings Outlook
Via Benzinga
Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.